Search results for " symptoms"

showing 10 items of 664 documents

The Eveningness Chronotype and Lower Adherence to the Mediterranean Diet Are Associated With Depressive Symptoms in Older Subjects With Metabolic Syn…

2021

OBJECTIVES: Studies have shown the importance of depression as a risk factor for several diseases. Likewise, currently there is great interest on the role of chronotype in depressive disorders. Similarly, associations between diet and depression have been reported. However, very few studies have analyzed the combined effect of diet and chronotype on depression. Our aim was to investigated the joint influence of the morning/evening chronotype and adherence to the Mediterranean diet (MeDiet) on depressive symptoms in older subjects with metabolic syndrome. METHODS: We analyzed 465 PREDIMED Plus-Valencia study participants (aged 55–75). We assessed depressive symptoms by the Beck Depression In…

Nutrition and DieteticsMediterranean dietbusiness.industrymedicineMedicine (miscellaneous)ChronotypeMetabolic syndromemedicine.diseasebusinessDepressive symptomsNeuroscience/Nutrition and the BrainFood ScienceClinical psychology
researchProduct

Adhd-like symptoms in children affected by obstructive sleep apnea syndrome: A case-control study

2016

Introduction: ADHD is characterized by inattention, hyperactivity, impulsivity, or a combination of these symptoms. Sleep disorders may be considered as a not secondary underlying cause of ADHD and growing evidence evidenced that obstructive sleep apnea syndrome (OSA) symptoms may overlap ADHD's ones. Aim of the present study is verifying the presence of ADHD-like symptoms in other frequent condition such as sleep-related breathing disorders in pediatric age. Materials and methods: 34 children (19 males and 15 females) aged 6-10 years (mean age 9.706 ± 3.434) with polysomnographic diagnosis of OSA, according to ICSD-3 criteria, were recruited. Control group was composed by 89 typical develo…

OSAObstructive sleep apnea syndromeSettore M-PSI/04 - Psicologia Dello Sviluppo E Psicologia Dell'EducazioneMedicine (all)ADHD; ADHD-like symptoms; Obstructive sleep apnea syndrome; OSA; Medicine (all)ADHDADHD-like symptomSettore MED/39 - Neuropsichiatria Infantile
researchProduct

Caliper navigation for craniotomy planning of convexity targets.

2021

Introduction A technique to localize a radiological target on the head convexity fast and with acceptable precision is sufficient for surgeries of superficial intracranial lesions, and of help in the setting of emergency surgery, computer navigation breakdown, limited resources and education. We present a caliper technique based on fundamental geometry, with inexpensive and globally available tools (conventional CT or MRI image viewer, calculator, caliper). Methods The distances of the radiological target from two landmarks (nasion and porus acusticus externus) are assessed with an image viewer and Pythagoras’ theorem. The two distances are then marked around the landmarks onto the head of…

Offset (computer science)Computer sciencemedicine.medical_treatmentDistance MeasurementConvexityDiagnostic RadiologyNervous System ProceduresMedicine and Health SciencesComputer navigationMusculoskeletal SystemCraniotomyMeasurementMultidisciplinaryRadiology and ImagingQRBrainMagnetic Resonance ImagingNavigationmedicine.anatomical_structureSurgery Computer-AssistedMedicineEngineering and TechnologyNasionAnatomyCraniotomyResearch ArticleImaging TechniquesScienceSurgical and Invasive Medical ProceduresResearch and Analysis MethodsImaging Three-DimensionalSigns and SymptomsDiagnostic MedicinemedicineHumansRC346-429NeuronavigationSkeletonScalpbusiness.industrySkullBiology and Life SciencesLesionsIntracranial lesionsCalipersNeurology. Diseases of the nervous systemClinical MedicineNuclear medicinebusinessTomography X-Ray ComputedLimited resourcesHeadPloS one
researchProduct

Effect of antipsychotic drugs on cortical thickness. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine.

2012

Abstract Background Imaging evidence indicates that brain alterations are primary to the full-blown onset of schizophrenia and seem to progress across time. The potential effects of antipsychotic medication on brain structure represent a key factor in understanding brain changes in psychosis. We aimed to investigate the effects of low doses of haloperidol, risperidone and olanzapine on cortical thickness. Method We investigated the effects of risperidone (N = 16), olanzapine (N = 18) and low doses of haloperidol (N = 18) in cortical thickness changes during 1-year follow-up period in a large and heterogeneous sample of schizophrenia spectrum patients. The relationship between cortical thick…

OlanzapineAdultMalemedicine.medical_specialtyPsychosisAdolescentmedicine.medical_treatmentNeuropsychological TestsBenzodiazepinesYoung AdultDouble-Blind MethodInternal medicinemedicineHaloperidolImage Processing Computer-AssistedHumansAntipsychoticScale for the Assessment of Negative SymptomsBiological PsychiatryAgedRetrospective StudiesCerebral CortexPsychiatric Status Rating ScalesAnalysis of VarianceRisperidoneVoxel-based morphometryMiddle Agedmedicine.diseaseRisperidoneMagnetic Resonance ImagingPsychiatry and Mental healthEndocrinologyFrontal lobeOlanzapineSchizophreniaHaloperidolFemalePsychologyCognition Disordersmedicine.drugClinical psychologyAntipsychotic AgentsFollow-Up StudiesSchizophrenia research
researchProduct

Ten-year assessment of a cancer fast-track programme to connect primary care with oncology: reducing time from initial symptoms to diagnosis and trea…

2021

Background Cancer is the second leading cause of mortality worldwide. Integrating different levels of care by implementing screening programmes, extending diagnostic tools and applying therapeutic advances may increase survival. We implemented a cancer fast-track programme (CFP) to shorten the time between suspected cancer symptoms, diagnosis and therapy initiation. Patients and methods Descriptive data were collected from the 10 years since the CFP was implemented (2009-2019) at the Clinico-Malvarrosa Health Department in Valencia, Spain. General practitioners (GPs), an oncology coordinator and 11 specialists designed guidelines for GP patient referral to the CFP, including criteria for br…

OncologyCancer Researchmedicine.medical_specialtyLung NeoplasmsConstitutional symptomsPrimary careMedical Oncologyprimary careBreast cancerGeneral PractitionersInternal medicinemedicineearly diagnosticHumanscancerGastrointestinal cancerStage (cooking)Lung cancerReferral and ConsultationOriginal ResearchPrimary Health Carebusiness.industryCancermedicine.diseaseOncologyFast trackbusinessESMO open
researchProduct

Isolated Nodal TBC Reactivation in a Patient with Post-Thrombocythemia Myelofibrosis Treated with Ruxolitinib: Case Report and Review of the Literatu…

2021

Ruxolitinib side effects include the most frequent hematological toxicity along with a more recently evidenced immunosuppressive activity, interfering both with the innate and adaptive immunity, and several cases of reactivation of latent infections by opportunistic agents in patients in treatment with ruxolitinib have been published in the last years. Several pathophysiological mechanisms may explain an association between ruxolitinib and opportunistic infections. From what we know, the only case of an isolated lymph node TBC reactivation in a ruxolitinib-treated myelofibrosis (MF) patient was reported by Patil et al. in 2016 [Int J Med Sci Public Health. 2017;6(3):1]. Other 10 cases descr…

Oncologymedicine.medical_specialtyRuxolitinibConstitutional symptomsSettore MED/15 - Malattie Del SangueHematological toxicityInternal medicineDrug DiscoverymedicinePharmacology (medical)In patientMyelofibrosisProspective cohort studyLymph nodePharmacologybusiness.industryInfection Myelofibrosis Reactivation Tuberculosis Ruxolitinib TBCGeneral Medicinemedicine.diseaseInfectious Diseasesmedicine.anatomical_structureOncologySputummedicine.symptombusinessmedicine.drug
researchProduct

Impact of Pre-Transplant Ruxolitinib in Myelofibrosis Patients on Outcome after Allogeneic Stem Cell Transplantation

2016

Abstract Introduction Ruxolitinib is the first approved drug for treatment of myelofibrosis. Major effects are reduction in spleen size and improvement of constitutional symptoms. Because spleen size and constitutional symptoms may influence outcome after allogeneic stem cell transplantation (ASCT), ruxolitinib is recommended before stem cell transplantation in order to reduce therapy-related morbidity and mortality and improve outcome (EBMT/ELN recommendation, Leukemia 2015) The aim of this retrospective study was to evaluate the impact of pretreatment with ruxolitinib in comparison to transplantation of ruxolitinib-naïve MF patients with regard to outcome after ASCT. Patients and methods …

Oncologymedicine.medical_specialtyRuxolitinibConstitutional symptomsmedicine.medical_treatmentImmunologyHematopoietic stem cell transplantationBiochemistry03 medical and health sciences0302 clinical medicineMedian follow-upInternal medicinemedicineMyelofibrosis030304 developmental biology0303 health sciencesbusiness.industryCell BiologyHematologymedicine.disease3. Good healthSurgeryTransplantationLeukemiabusinessBusulfan030215 immunologymedicine.drugBlood
researchProduct

The Utility of BDNF Detection in Assessing Severity of Huntington's Disease.

2021

Brain-derived neurotrophic factor (BDNF) is involved in the survival and maturation of neurons, and also promotes and controls neurogenesis. Its levels are lowered in many neurodegenerative diseases, including Huntington’s disease (HD). Clinical pictures of HD can be very diverse, which makes it difficult to assess its severity

Oncologymedicine.medical_specialtymedicine.diagnostic_testbusiness.industryNeurogenesisRNeurological examinationGeneral MedicineDiseasemedicine.diseaseMotor symptomsArticleBDNFHuntington's diseasenervous systemNeurotrophic factorsInternal medicineHealthy volunteersmedicineMedicinedisease severitybusinessCognitive impairmentHuntington’s diseaseJournal of clinical medicine
researchProduct

Transformational leadership and depressive symptoms among employees : mediating factors

2014

Purpose– The purpose of this paper is to examine whether the link between transformational leadership and depressive symptoms among employees is mediated by such personal resources as occupational self-efficacy, perceived meaningfulness of the work, and work-related rumination.Design/methodology/approach– The study was conducted using questionnaires among 557 Finnish municipal employees in various occupations. The statistical analysis was based on structural equation modeling. A multiple mediation model enabled us to investigate the specific indirect effects of each mediator. Model comparison was applied to ascertain whether the mediation should be considered as full or partial.Findings– Re…

Organizational Behavior and Human Resource ManagementMediation (statistics)pystyvyysuskoStructural equation modelingtransformationaalinen johtajuustyön merkityksellisyysdepressiotransformational leadershipmedicinemediationmeaningful workDepressive symptomsSelf-efficacymediaattoriPsykologia - Psychologyruminationtyöstä irrottautuminenHealth promotionTransformational leadershipNegative relationshipRumination(mental) depressionBusiness Management and Accounting (miscellaneous)medicine.symptomPsychologyself-efficacyClinical psychology
researchProduct

Pregabalin in the treatment of inferior alveolar nerve paraesthesia following overfilling of endodontic sealer

2014

A case of orofacial pain and inferior alveolar nerve (IAN) paraesthesia after extrusion of endodontic sealer within the mandibular canal treated with prednisone and pregabalin is described. A 36-year-old woman underwent root canal treatment of the mandibular second right premolar tooth. Post-operative panoramic radiograph revealed the presence of radiopaque canal sealer in the mandibular canal. Damage to IAN consecutive to extrusion of endodontic sealer was diagnosed. Non-surgical management was decided, including: 1 mg/kg/day prednisone 2 times/day, once-daily regimen, and 150 mg/day pregabalin, two doses per day, monitoring the progress with periodic follow-up visits. Six weeks after the …

Orofacial painmedicine.medical_specialtyOrofacial painPanoramic radiographRoot canalPregabalinMandibular canalDentistrySigns and symptomsCase ReportOdontologíaInferior alveolar nerveEndodonticsTractament del dolorstomatognathic systemPrednisonemedicinePain treatmentEndodònciaGeneral DentistryOral Medicine and Pathologybusiness.industry:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludSurgerymedicine.anatomical_structureUNESCO::CIENCIAS MÉDICASmedicine.symptombusinessDolor orofacialmedicine.drug
researchProduct